<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01668927</url>
  </required_header>
  <id_info>
    <org_study_id>rjkls_2012009</org_study_id>
    <nct_id>NCT01668927</nct_id>
  </id_info>
  <brief_title>Empirical Rescue Therapies of Helicobacter Pylori Infection</brief_title>
  <official_title>Helicobacter Pylori Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The increase of antibiotic resistance to H. pylori causes failure of treatment. Furazolidone,
      amoxicillin and tetracycline are good candidates for rescue therapy since resistance to these
      three antimicrobials was rare. It is necessary to assess the efficacy and safety of these
      four bismuth-containing quadruple regimens with above antibiotics as empirical rescue
      therapies for H. pylori eradication.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>eradication rate of H. pylori</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">424</enrollment>
  <condition>Functional Dyspepsia</condition>
  <condition>Scarred Peptic Ulcer</condition>
  <arm_group>
    <arm_group_label>tetracycline/furazolidone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one of the four empirical rescue therapies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>amoxicillin/tetracycline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one of the four empirical rescue therapies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>amoxicillin/furazolidone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one of the four empirical rescue therapies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tetracycline /metronidazole</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Classical rescue therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Proton Pump Inhibitor</intervention_name>
    <arm_group_label>tetracycline/furazolidone</arm_group_label>
    <arm_group_label>amoxicillin/tetracycline</arm_group_label>
    <arm_group_label>amoxicillin/furazolidone</arm_group_label>
    <arm_group_label>tetracycline /metronidazole</arm_group_label>
    <other_name>Lansoprazole</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bismuth</intervention_name>
    <arm_group_label>tetracycline/furazolidone</arm_group_label>
    <arm_group_label>amoxicillin/tetracycline</arm_group_label>
    <arm_group_label>amoxicillin/furazolidone</arm_group_label>
    <arm_group_label>tetracycline /metronidazole</arm_group_label>
    <other_name>Bismuth potassium citrate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole</intervention_name>
    <arm_group_label>tetracycline /metronidazole</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tetracycline</intervention_name>
    <arm_group_label>tetracycline/furazolidone</arm_group_label>
    <arm_group_label>amoxicillin/tetracycline</arm_group_label>
    <arm_group_label>tetracycline /metronidazole</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Furazolidone</intervention_name>
    <arm_group_label>tetracycline/furazolidone</arm_group_label>
    <arm_group_label>amoxicillin/furazolidone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin</intervention_name>
    <arm_group_label>amoxicillin/tetracycline</arm_group_label>
    <arm_group_label>amoxicillin/furazolidone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  H. pylori -positive patients with functional dyspepsia and scarred peptic ulcers who
             had previously failed one or more eradication regimens containing clarithromycin,
             metronidazole and/or amoxicillin.

        Exclusion Criteria:

          -  less than 18 years old, never receiving eradication treatment before, with previous
             gastric surgery, pregnancy, lactation, major systemic diseases, administration of
             antibiotics, bismuth, antisecretory drugs in the preceding 8 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2012</study_first_submitted>
  <study_first_submitted_qc>August 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2012</study_first_posted>
  <last_update_submitted>June 1, 2013</last_update_submitted>
  <last_update_submitted_qc>June 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Dr. HONG LU</investigator_full_name>
    <investigator_title>professor of GI Division, Renji Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspepsia</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Tetracycline</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Furazolidone</mesh_term>
    <mesh_term>Lansoprazole</mesh_term>
    <mesh_term>Proton Pump Inhibitors</mesh_term>
    <mesh_term>Bismuth</mesh_term>
    <mesh_term>Potassium Citrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

